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ABSTRACT 26 
A presynaptic adhesion G-protein-coupled receptor, latrophilin-1, and a postsynaptic 27 
transmembrane protein, Lasso/teneurin-2, are implicated in trans-synaptic interaction that 28 
contributes to synapse formation. Surprisingly, during neuronal development, a substantial 29 
proportion of Lasso is released into the intercellular space by regulated proteolysis, potentially 30 
precluding its function in synaptogenesis. We found that released Lasso binds to cell-surface 31 
latrophilin-1 on axonal growth cones. Using microfluidic devices to create stable gradients of 32 
soluble Lasso, we show that it induces axonal attraction, without increasing neurite outgrowth. 33 
Using latrophilin-1 knockout in mice, we demonstrate that latrophilin-1 is required for this effect. 34 
After binding latrophilin-1, Lasso causes downstream signaling, which leads to an increase in 35 
cytosolic calcium and enhanced exocytosis, processes that are known to mediate growth cone 36 
steering. These findings reveal a novel mechanism of axonal pathfinding, whereby latrophilin-1 37 
and Lasso mediate both short-range interaction that supports synaptogenesis, and long-range 38 
signaling that induces axonal attraction.  39 
 40 
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INTRODUCTION 43 
Correct wiring of the nervous system critically depends on both long-range diffusible cues and 44 
short-range contact-mediated factors which can be attractive or repulsive (Chen and Cheng, 45 
2009). However, the relatively small repertoire of key molecules known to be involved in axon 46 
guidance or trans-synaptic adhesion cannot fully explain the complexity and specificity of synaptic 47 
connections. Indeed, new interacting partners and signal-modulating ligands are now being found 48 
for many well-established guidance factors (Karaulanov et al., 2009; Leyva-Diaz et al., 2014; 49 
Sollner and Wright, 2009). Furthermore, our novel findings demonstrate that at least one receptor 50 
pair can both mediate cell contacts and, unexpectedly, also act as a long-range signaling factor 51 
and its receptor.  52 
This trans-synaptic receptor pair consists of presynaptic latrophilin-1 (LPHN1) and postsynaptic 53 
Lasso (Silva et al., 2011). LPHN1 (also known as ADGRL1 for Adhesion G-protein-coupled 54 
Receptor, Latrophilin subfamily 1 (Hamann et al., 2015)) is a cell-surface receptor that is 55 
expressed by all central neurons (Davletov et al., 1998; Ichtchenko et al., 1999; Matsushita et al., 56 
1999; Sugita et al., 1998). An array of data indicates that LPHN1 is localized on axons, axonal 57 
growth cones and nerve terminals (Silva et al., 2011). Activation of LPHN1 by its agonist, mutant 58 
latrotoxin (LTXN4C), stimulates vesicular exocytosis (Ashton et al., 2001; Lajus et al., 2006; 59 
Lelyanova et al., 2009; Silva et al., 2009; Tobaben et al., 2002; Volynski et al., 2003; Deák et al., 60 
2009). LPHN1 knockout (KO) in mice leads to abnormal rates of embryonic lethality and psychotic 61 
phenotypes (Tobaben et al., 2002), indicating the importance of LPHN1 in early development and 62 
in cognitive functions in adulthood. 63 
The second member of this receptor pair, Lasso, is a representative of teneurins (TENs), large 64 
single-pass transmembrane proteins (Baumgartner et al., 1994; Levine et al., 1994). Lasso is the 65 
splice variant of TEN2 (TEN2-SS) (Figure 1A) that specifically binds LPHN1 in cell adhesion 66 
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experiments (Li et al., 2018). Given also that only Lasso is isolated by affinity chromatography on 67 
LPHN1 (Silva et al., 2011), we will refer here to TEN2 that is able to bind LPHN1 as Lasso. All 68 
TENs possess a large C-terminal extracellular domain (ECD) containing a series of epidermal 69 
growth factor (EGF)-like repeats and other repeat domains (Figure 1A). Inter-chain disulfide 70 
bridges mediate TEN homodimerization (Figure 1B, left) (Feng et al., 2002; Vysokov et al., 2016). 71 
Similar to Notch, during the intracellular processing of TENs, their ECDs are constitutively cleaved 72 
by furin at site 1 (Figure 1A, B, left) (Rubin et al., 1999; Tucker and Chiquet-Ehrismann, 2006; 73 
Vysokov et al., 2016). However, the cleaved ECD remains tightly tethered to the cell surface due 74 
to its strong interaction with the transmembrane fragment (Figure 1B, middle) (Vysokov et al., 75 
2016).  76 
TENs have been implicated in promoting axon guidance and neurite outgrowth (Minet et al., 1999; 77 
Rubin et al., 1999; Antinucci et al., 2013; Leamey et al., 2007; Young et al., 2013; Hor et al., 78 
2015). For example, different TENs can mediate neuronal cell adhesion (Boucard et al., 2014; 79 
Rubin et al., 2002; Silva et al., 2011). TEN2 and TEN4, which are present on dendritic growth 80 
cones and developing filopodia, may be responsible for dendritic spine formation (Rubin et al., 81 
1999; Suzuki et al., 2014), while substrate-attached TEN1 supports neurite growth (Minet et al., 82 
1999). However, a mechanistic insight into the role of TENs in axonal growth is still lacking.  83 
One possibility is that TENs, as bona fide cell-surface receptors, could bind other cell-surface 84 
molecules and thus mediate axonal pathfinding. TENs can form homophilic complexes (Rubin et 85 
al., 2002; Beckmann et al., 2013). However, TENs failed to mediate homophilic cell adhesion in 86 
direct experiments (Boucard et al., 2014; Li et al., 2018). In addition, homophilic interactions of a 87 
recombinant soluble TEN2 ECD with the cell-surface TEN2 inhibited (rather than promoted) 88 
neurite outgrowth (Beckmann et al., 2013; Young et al., 2013). By contrast, heterophilic 89 
interactions of TENs can promote synapse formation (Mosca et al., 2012; Silva et al., 2011). More 90 
specifically, heterophilic interaction between Lasso and LPHN1, its strongest ligand (Silva et al., 91 
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2011; Boucard et al., 2014), consistently mediates cell adhesion (Silva et al., 2011; Boucard et 92 
al., 2014; Le et al., 2018) and is thought to facilitate synapse formation (Silva et al., 2011).  93 
However, our surprising finding (Vysokov et al., 2016) that Lasso/TEN2 is partially released from 94 
the cell surface by regulated proteolysis (at site 3; Figure 1B, right) was inconsistent with a cell-95 
surface function of Lasso. On the other hand, we found that the released Lasso fragment retained 96 
its ability to bind cell-surface LPHN1 with high affinity and induce intracellular signaling (Silva et 97 
al., 2011; Vysokov et al., 2016). Thus, it was possible that the released, soluble ECD of 98 
Lasso/TEN2 could act as a diffusible (attractive or repulsive) factor and mediate some of the 99 
TEN2 functions in neurite pathfinding described above. Therefore, we hypothesized that the 100 
binding of soluble Lasso to LPHN1 on distant neurites could trigger important changes in their 101 
growth. 102 
We tested this hypothesis using cultured hippocampal neurons. First, we show that developing 103 
neurons release a substantial proportion of Lasso ECD into the medium, while LPHN1 is 104 
concentrated on the leading edge of axonal growth cones. We then use microfluidic chambers to 105 
demonstrate that a spatio-temporal gradient of soluble Lasso attracts neuronal axons, but not 106 
dendrites, and that this process involves LPHN1 that is present on axonal growth cones. Using 107 
model cells expressing functional LPHN1, and mouse neuromuscular preparations, we also show 108 
that LPHN1 activation by soluble Lasso causes intracellular Ca2+ signaling, which leads to 109 
increased exocytosis. This suggests a plausible cellular mechanism causing axons to turn in the 110 
direction of a gradient of soluble Lasso. Moreover, the LPHN1-Lasso pair illustrates a novel 111 
principle of chemical guidance whereby cell-surface receptors engage not only in short-range 112 
interactions, but also in long-range signaling, which can further contribute to the formation of 113 
complex neuronal networks. 114 
RESULTS 115 
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Neurons partially cleave and release Lasso  116 
We previously showed in model cell lines and in adult brain that Lasso is cleaved at several sites 117 
(sites 1, 2, 3 in Figure 1A, B) and is released into the extracellular environment in a regulated 118 
manner (Vysokov et al., 2016). To test whether Lasso undergoes the same processing and 119 
release during neuronal development, we followed Lasso expression at different stages of neuron 120 
maturation in hippocampal cell cultures (Kaech and Banker, 2006). Soon after plating, embryonic 121 
(E18) rat hippocampal neurons produced Lasso, which was detectable at 3 days in vitro (DIV) 122 
(Figure 1C, D). A large proportion of Lasso (~90%) was constitutively cleaved at site 1 during 123 
neuronal development in vitro (Figure S1A). Increasing amounts of cleaved fragment also 124 
appeared in the medium at 7 and 14 DIV (Figure 1D and S1A, green), indicating a slow cleavage 125 
at site 3. Thus, Lasso is fully cleaved at site 1 and partially released by regulated cleavage at site 126 
3 not only in transfected immortalized cells, but also in developing neurons and in the postnatal 127 
rat brain (Vysokov et al., 2016). 128 
We also examined the neuronal structures that could release soluble Lasso ECD. We found that 129 
large amounts of Lasso were present on dendrites and dendritic growth cones (Figure S1B), while 130 
it was practically absent from axons and axonal growth cones (Figure 1E). Since about 80% of 131 
Lasso was not normally released (Figure 1D, S1A), these data suggested that the compartments 132 
rich in Lasso, i.e. dendrites and dendritic growth cones, were the main source of the soluble Lasso 133 
fragment. 134 
LPHN1 is expressed on growth cones of developing neurons 135 
As early as 3 DIV, the developing neurons also expressed LPHN1, the high-affinity receptor for 136 
soluble Lasso ECD, and the amounts of LPHN1 continued to increase through all time points (Fig 137 
1B), in parallel with the increasing amounts of soluble Lasso (Fig S1A). This correlation between 138 
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the soluble Lasso and cell-surface LPHN1 further supported the idea of their likely interaction 139 
during neuronal development.  140 
Interestingly, in developing hippocampal neurons, LPHN1 was found concentrated in axons and 141 
especially in axonal growth cones, where it co-localized with synapsin (Figure S1C, D, 142 
arrowheads). LPHN1 was also enriched in axonal varicosities, which were identified as en 143 
passant synapses by immunostaining for PSD-95 (Figure S1D, asterisks).  144 
We then studied the expression of LPHN1 in growth cones in more detail by transfecting 145 
hippocampal neurons with GFP, which greatly simplified the identification and tracking of axons 146 
and axonal growth cones. All GFP-labeled axonal growth cones showed a clear enrichment of 147 
endogenous LPHN1 (Figure 1F, G, I). Conversely, when LPHN1 expression was knocked down 148 
by shRNA (delivered together with GFP in the same bicistronic vector), it clearly disappeared from 149 
the growth cones of transfected neurons, while the growth cones of non-transfected cells were 150 
not affected (Figure S1E, arrow and arrowhead, respectively). 151 
We also discovered that endogenous LPHN1 expression within axonal growth cones was 152 
polarized LQ UHODWLRQ WR WKH FRQH¶V V\PPHWU\ D[LV, such that one side of each growth cone 153 
contained on average 1.88 ± 0.22 fold more LPHN1 than the other (Figure 1G, H). To assess 154 
whether this LPHN1 enrichment correlated with the direction of axonal growth, we traced the 155 
growth trajectories of a number of symmetrical growth cones and compared these with the 156 
distribution of LPHN1. This analysis clearly demonstrated that LPHN1 polarization within the 157 
growth cones very strongly positively correlated with the direction of their turning (Figure 1G, H). 158 
Moreover, in non-symmetrical growth cones, which had clearly started turning prior to fixation, 159 
LPHN1 expression had a bimodal distribution, being enriched not only QHDUWKH³QHFN´RIDWXUQLQJ160 
cone, but also close to its leading edge (Figure S1F, G). Such leading-edge enrichment also 161 
extended into fine growth cone protrusions. Thus, filopodia and lamellipodia located on the 162 
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leading edge of a growth cone (Figure 1I, left, arrowheads) showed a much higher amount of 163 
LPHN1 than the processes on the trailing edge of the growth cone (Figure 1I, right).  164 
We concluded that LPHN1 expression within growth cones correlated positively with the global 165 
GLUHFWLRQDOLW\RIJURZWKDQGZLWKWKHILQHVWUXFWXUHVWKDWXQGHUSLQWKHJURZWKFRQH¶VH[WHQVLRQ 166 
Soluble Lasso binds to cell-surface LPHN1 167 
Next, we tested the interaction between soluble Lasso and cell-surface LPHN1. For these tests 168 
we expressed a shorter, constitutively secreted construct, Lasso-D (Figure 2A, right) in HEK293A 169 
cells and affinity-purified it (Figure 2B). 100 nM Lasso-D was incubated with neuroblastoma cells 170 
stably expressing (i) LPHN1, (ii) a chimeric construct LPH-82 containing ECD from EMR-2 used 171 
as a negative control, (iii) Lasso-A, or (iv) Lasso-FS (Figure 2A, left). As expected, Lasso-D did 172 
not interact with LPH-82 (Figure 2C, panel 4). The lack of Lasso-D binding to Lasso-A and 173 
released fragment of Lasso-A binding to Lasso-FS (Figure 2D, panels 2, 3; Figure 2²supplement 174 
1, B) was somewhat surprising, since homophilic interactions between membrane-bound and 175 
soluble TENs were reported previously (Bagutti et al., 2003; Beckmann et al., 2013; Hong et al., 176 
2012; Rubin et al., 2002; Boucard et al., 2014), but this could be due to a relatively low affinity of 177 
Lasso-Lasso interaction and relatively long washes employed in our protocol. On the other hand, 178 
and consistent with previous reports of high affinity between LPH1 and Lasso (Silva et al., 2011; 179 
Boucard et al., 2014), Lasso-D and the released fragment of Lasso-A bound strongly to cells 180 
expressing LPHN1 (Figure 2C, panels 2, 3 and Figure 2²supplement 1, A). 181 
To verify that the soluble ECD of Lasso, when proteolytically released from the cell-surface as 182 
depicted in Figure 2A (Lasso-A), could diffuse between individual cells and bind LPHN1 on distant 183 
cells, we co-cultured neuroblastoma cells stably expressing Lasso-A with cells stably expressing 184 
LPHN1. When co-cultured at high density, these cells formed clusters, held together by 185 
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LPHN1/Lasso-A intercellular adhesion complexes (Fig 2E, panel 1). In more sparsely plated co-186 
cultures, the Lasso-A fragment was released into the medium, where it diffused and bound to 187 
cells expressing LPHN1, but not to the wild type (WT) neuroblastoma cells (Figure 2E, panel 2, 188 
and Figure 2²supplement 1, C). Interestingly, after binding Lasso, the LPHN1 staining appeared 189 
to concentrate in large patches, a pattern very different from LPHN1 distribution in control 190 
conditions (Figure 2C, panel 1) (see also below). These experiments suggest that (i) when Lasso 191 
is released into the medium as a result of its regulated cleavage, it retains its affinity for LPHN1 192 
and (ii) on reaching distant LPHN1-expressing cells by diffusion, Lasso causes LPHN1 193 
redistribution on the cell surface.  194 
We then asked whether the soluble Lasso ECD could similarly bind to LPHN1 in neurons and, 195 
more specifically, on axonal growth cones. To control for the specificity of Lasso binding to 196 
LPHN1, this experiment was carried out on cultured hippocampal neurons from LPHN1 WT 197 
(Adgrl1+/+) and LPHN1 KO (Adgrl1-/-) newborn mice (P0). Also, to unequivocally distinguish 198 
between the soluble and cell-surface Lasso, we used exogenous Lasso-D, which was detected 199 
using anti-FLAG antibody. As expected, in WT mouse neurons, LPHN1 was found mostly in 200 
axonal growth cones (arrowheads) and varicosities (asterisks) (Figure 2²supplement 2, A, 201 
green). The exogenous Lasso-D clearly bound to these structures (Figure 2²supplement 2, A, 202 
red; C), but in general did not interact with dendrites. By contrast, the axons and growth cones of 203 
LPHN1 KO neurons did not show specific LPHN1 staining and appeared unable to bind the 204 
soluble exogenous Lasso-D (Figure 2²supplement 2, B, C). These results indicated that 205 
released Lasso ECD could interact with LPHN1 on axonal growth cones. 206 
MAIDs as a tool to study axonal responses to chemoattractant gradients 207 
Based on the data above, we hypothesized that the interaction of released Lasso ECD with 208 
LPHN1 on axonal growth cones could represent one of the mechanisms that underlie the 209 
10 
previously formulated, but so far unexplained, role of TENs in axonal pathfinding and brain 210 
patterning (Antinucci et al., 2013; Hor et al., 2015; Leamey et al., 2007; Young et al., 2013). To 211 
study this effect, we developed a new method of long-term exposure of hippocampal axons to 212 
stable gradients of Lasso using ³microfluidic axon isolation devices´ (MAIDs) (Figure 3A). The 213 
advantage of this method over conventional ligand-puffing was that the MAIDs enabled exposure 214 
of axons to long-term stable gradients of Lasso, which was critical for our assay. The device used 215 
here had two compartments, each consisting of two cylindrical wells connectHGE\D³corridor´; a 216 
150 ȝP-thick wall that separated the two corridors had multiple parallel microchannels (2-3 ȝP217 
tall and 10 ȝPZLGH) connecting the two compartments (Figure 3A, middle). When neurons are 218 
plated in one of the compartments (designated as the Somal Compartment), their neurites grow 219 
in all directions, but only the axons (identified by NF-H staining) readily penetrate the 220 
microchannels and cross into the empty, Axonal Compartment (Figure 3A, right; 3B, C). While 221 
there is a large number of dendrites in the Somal Compartment (identified by microtubule-222 
associated protein 2, MAP-2, staining), only a few of them enter the Axonal Compartment and 223 
then terminate close to the wall (Figure 3B, C).  224 
From the previously described physical characteristic of microfluidic chambers (Zicha et al., 225 
1991), we predicted that a concentration gradient across the microchannels in our devices could 226 
be established over time. This was modelled by adding TRITC-conjugated BSA to one 227 
compartment and visualizing the dye in the microchannels (Figure 3D). We found that a gradient 228 
was formed within the first 24 h and remained stable over several days (Figure 3D, E). 229 
To test the functionality of the MAIDs for studying axonal guidance, we employed brain-derived 230 
neurotrophic factor (BDNF) known to act as an axonal chemoattractant (Li et al., 2005). Rat 231 
hippocampal neurons were plated into the Somal Compartment, and at 3 DIV, when axons 232 
normally start entering microchannels, BDNF was added to the Axonal Compartment (PBS was 233 
added to control cultures) (Figure 3F). After a further 5 DIV, we observed a 2.2-fold higher number 234 
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of axons crossing into the Axonal Compartment in the presence of BDNF compared with the 235 
control (Figure 3G, H). This effect was statistically significant (Figure 3H). This proof-of-concept 236 
experiment confirmed that MAIDs could be used to study the long-term effects of chemoattractant 237 
gradients on axonal migration. 238 
A gradient of soluble Lasso induces axonal attraction 239 
We then used this methodology to study the reaction of LPHN1-expressing neuronal growth 240 
cones to a gradient of soluble released Lasso. Lasso-D was added to the Axonal Compartment 241 
(Figure 4A), and the integrity of Lasso during the experiment was verified by Western blotting 242 
(Figure 4B). Quantification of axons in Axonal Compartments by NF-H immunofluorescence 243 
(Figure 4C, D) revealed a statistically significant 1.5-fold increase in axonal growth induced by 244 
Lasso-D. Thus, soluble Lasso-D clearly functioned as an attractant of axonal elongation and/or 245 
steering.  246 
Since LPHN1 is present on axonal growth cones (Figs. 1, S1), binds soluble Lasso (Figure 2, 247 
Figure 2²supplement 1) and is the strongest interacting partner of Lasso (Boucard et al., 2014; 248 
Silva et al., 2011), we hypothesized that LPHN1 may be involved in the observed Lasso-mediated 249 
attraction of axons (Figure 4²supplement 1, A). To investigate this, hippocampal cultures from 250 
LPHN1 KO or WT mice (genotyping shown in Figure 4²supplement 1, B) were exposed to a 251 
gradient of Lasso-D added to the Axonal Compartment. The total amount of neurites and cells in 252 
both compartments were quantified using the lipophilic membrane tracer DiO (see Methods for 253 
details). The results clearly demonstrated that the neurites from LPHN1-expressing (WT) 254 
hippocampal neurons crossed into the Lasso D-containing Axonal Compartment 5.5-fold more 255 
readily than the neurites from neurons lacking this receptor (Figure 4E, left). Importantly, this 256 
effect was not due to a lower viability of LPHN1 KO neurons, because there was no difference 257 
between the KO and WT cells within the Somal Compartment (Figure 4E, right).  258 
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We also studied the behavior of axons in response to a spatio-temporal Lasso gradient in the 259 
corridor of the Axonal Compartment, by exposing axons to an increasing concentration of the 260 
attractant during the whole growth process. In order to achieve a stable increase in protein 261 
concentration over time, we seeded HEK293A cells stably expressing soluble Lasso-D 262 
(untransfected HEK293A cells were used in control) into the wells of the Axonal Compartment 263 
(Figure 5A). The presence of secreted Lasso-D within the Axonal Compartments was verified at 264 
the end of each experiment (Fig 5B), and the distribution of axons was quantified by NF-H 265 
immunofluorescence (Figure 5C, D). In this experiment, we observed not only a significantly 266 
greater number of axons being attracted, but also axons growing deeper into the corridors of the 267 
Axonal Compartments (Figure 5D). On the other hand, quantification of MAP-2 268 
immunofluorescence demonstrated that released Lasso-D did not attract dendrites; in fact, there 269 
was a slight repulsive effect (Figure 5E). Taken together, these experiments indicate that a 270 
gradient of the soluble Lasso fragment specifically induces axonal attraction. 271 
Soluble Lasso fragment also induced strong axonal fasciculation (e.g. Figure 4C and 5C). This 272 
effect was quantified by measuring WKHZLGWKRID[RQDOEXQGOHVDWȝPIURP the separating 273 
wall, where axons grew mostly away from the wall rather than along it. Based on the average 274 
width of a single axon (1 µm), an average bundle contained 2-3 axons in control conditions, but 275 
more than 5 axons in the presence of 1.5 nM Lasso-D (Figure 5F). Thus, Lasso fragment can 276 
induce axonal fasciculation in a concentration-dependent manner.  277 
In order to rule out the possibility that the observed effects of the released Lasso fragment were 278 
due to a general positive trophic effect (e.g. an increase in axonal elongation speed), Lasso-D 279 
was added directly to cultures of hippocampal neurons. To visualize axons, neurons were 280 
transfected with GFP prior to plating and allowed to grow for 4 DIV, after which the longest 281 
neurites of GFP-positive neurons were traced and measured. We did not detect any increase in 282 
the length of neurites when neurons were exposed to Lasso-D (Figure 5G, H).  283 
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Taken together, these data demonstrate unequivocally that a gradient of the soluble fragment of 284 
Lasso acts as an axonal attraction cue without affecting their overall growth. 285 
The mechanism of axonal attraction by Lasso 286 
To determine the downstream effects of the interaction between soluble Lasso ECD and LPHN1, 287 
we used neuroblastoma cells stably expressing LPHN1. It was reported previously that the 288 
signaling machinery downstream of LPHN1 in these cells is similar to that in neurons (Silva et al., 289 
2009; Volynski et al., 2004). When the LPHN1-expressing neuroblastoma cells are stimulated by 290 
the known LPHN1 ligand and potent secretagogue LTXN4C, the N-terminal and C-terminal 291 
fragments (NTF and CTF) of LPHN1 undergo rearrangement (as illustrated in Figure 6A, middle). 292 
In turn, this induces intracellular Ca2+ signaling which involves WKH DFWLYDWLRQ RI *Įq and 293 
phospholipase C (PLC), and release of inositol 1,4,5-trisphosphate (IP3) (Silva et al., 2009; 294 
Volynski et al., 2004).  295 
These observations suggested that Lasso might also affect the distribution of NTF and CTF of 296 
LPHN1 in the plasma membrane. Indeed, we noticed that soluble Lasso-D or Lasso-A caused 297 
the NTF to aggregate into patches on the surface (Figure 2C, panel 2; Figure 2²supplement 1, 298 
C). To test whether Lasso also causes a redistribution of the CTF required for intracellular 299 
signaling, we applied Lasso-D to LPHN1-expressing cells and followed the fate of both NTF and 300 
CTF. We observed a dramatic rearrangement of both LPHN1 fragments in the membrane, leading 301 
to the formation of large molecular aggregates also containing Lasso (Figure 6C). Similar 302 
clustering of both LPHN1 fragments was also induced by LTXN4C, a strong LPHN1 agonist (Figure 303 
6D). On the other hand, an antibody recognizing the V5 epitope at the N-terminus of NTF only 304 
caused NTF clustering, but did not affect the distribution of CTF (Figure 6A, right; Figure 6E). 305 
Thus, soluble Lasso ECD, which causes the association of the LPHN1 fragments, might be a 306 
functional agonist of LPHN1, similar to LTXN4C. By analogy, this also indicated that the soluble 307 
14 
Lasso fragment could induce signal transduction via the CTF of LPHN1 coupled to a G-protein.  308 
The effect of LTXN4C can be assessed by monitoring cytosolic Ca2+ (Silva et al., 2011; Volynski et 309 
al., 2004). We therefore investigated whether the soluble Lasso ECD could induce similar effects. 310 
LPH1-expressing neuroblastoma cells were stimulated with saturating concentrations of Lasso-311 
D, LTXN4C (positive control) or buffer (negative control), while cytosolic calcium levels were 312 
monitored using an intracellular Ca2+-sensing dye, Fluo-4 (see Figure 7²figure supplement 1, A 313 
for the scheme of experiment). Similar to LTXN4C, in the absence of extracellular Ca2+, Lasso-D 314 
did not cause any Ca2+ signals in LPHN1-expressing NB2a cells (Figure 7A). However, when 315 
extracellular Ca2+ was added to the cells, the rise in intracellular Ca2+ signal was significantly 316 
higher in the presence of the ECD of Lasso, compared to negative control (Figure 7A). Thus, 317 
Lasso-D is able to cause intracellular Ca2+ signaling in LPHN1-expressing cells. 318 
One of the features of LTXN4C-induced effects (such as Ca2+ signaling and neurotransmitter 319 
release) is that they develop with a delay of ~20 minutes, which has been attributed to the time 320 
taken by the toxin to assemble the LPHN1 fragments together and cause its maximal activation 321 
(Volynski et al., 2004). We predicted, therefore, that the rearrangement of the NTF and CTF 322 
induced by soluble Lasso (Figure 6C) should prepare the signaling machinery for stimulation by 323 
the toxin. To test this idea, we first treated the LPHN1-expressing cells with Lasso-D and then 324 
with LTXN4C (Figure 7²figure supplement 1, B). When Lasso-D was applied in the presence of 2 325 
mM Ca2+, it induced relatively short-lived intracellular Ca2+ signaling (Figure 7B, right, prior to the 326 
blue arrowhead). However, when LTXN4C was then added, it triggered Ca2+ signaling after a 327 
shorter delay (~14 min), instead of the usual ~23 min (Figure 7C). This additivity of effects is 328 
consistent with soluble Lasso inducing intracellular Ca2+ signaling via the same molecular 329 
mechanism as LTXN4C.  330 
Another well-known effect of LTXN4C is the burst-like release of neurotransmitters, linked to the 331 
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elevated levels of cytosolic Ca2+ (Lelyanova et al., 2009; Volynski et al., 2003). As Lasso-D 332 
likewise increased intracellular Ca2+ concentration, it might also trigger such transmitter 333 
exocytosis. To test this hypothesis, we applied a previously characterized (Silva et al., 2011), 334 
soluble, short C-terminal Lasso construct (Lasso-G, Figure 1A) to mouse neuromuscular 335 
preparations and recorded the spontaneous miniature end plate potentials (MEPPs), which 336 
correspond to individual exocytotic events. We found that incubation with Lasso-G significantly 337 
increased MEPPs frequency from 1.61 ± 0.27 Hz in control to 3.83 ± 0.79 Hz in the presence of 338 
Lasso-G (Figure 7D, E). However, this was much less than the effect of LTXN4C, which triggered 339 
massive secretion of neurotransmitter reaching 29.5 ± 4.1 Hz (Figure 7F). To ascertain that both 340 
these effects were mediated by LPHN1, we used neuromuscular preparations from LPHN1 KO 341 
mice. Interestingly, unstimulated LPHN1 KO motor neurons showed an increased MEPPs 342 
frequency compared to synapses from WT animals (3.33 ± 0.79 Hz in KO synapses). However, 343 
neither Lasso-G, nor LTXN4C had any effect on exocytosis in preparations lacking LPHN1 (Figure 344 
7E, F; 3.4 ± 0.68 Hz with Lasso-G and 3.8 ± 1.4 Hz with LTXN4C). In all the recordings, the mean 345 
amplitudes of MEPPs under any condition did not differ significantly (Figure 7²figure supplement 346 
1, C), which indicated a purely presynaptic effect of the two LPHN1 agonists and of LPHN1 347 
ablation. These results show that the soluble Lasso fragment can increase exocytosis at nerve 348 
terminals, and confirm the importance of LPHN1 in the observed effects of LTX and the ECD of 349 
Lasso. 350 
From the results reported here, we hypothesize that the soluble Lasso fragment, released by 351 
developing neurons, interacts with LPHN1 on axonal growth cones and nerve terminals. It then 352 
causes clustering of LPHN1 fragments and activation of downstream signaling, causing an 353 
increase in cytosolic Ca2+ and subsequent exocytosis. The latter two processes are known to be 354 
key regulators of axonal attraction (Tojima et al., 2011). Thus, the ability of soluble Lasso to 355 
activate these processes on axonal growth cones could underpin the mechanisms by which it 356 
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attracts axons.  357 
DISCUSSION 358 
This study provides evidence that Lasso (a splice variant of TEN2 lacking a 7-residue insert in 359 
WKHȕ-propeller domain, TEN2-SS) functions specifically as an attractant for axons expressing 360 
LPHN1, and proposes a molecular mechanism for this effect. By using microfluidic devices to 361 
create long-term gradients of soluble proteins (Figure 3), we demonstrate that a gradient of 362 
soluble ECD of Lasso can act as an attractant for axons from hippocampal neurons (Figs. 4, 5A-363 
E). Importantly, growing hippocampal neurons in a medium containing a uniform concentration of 364 
Lasso had no effect on the length of their axons (Figure 5G). This shows that Lasso plays an 365 
instructive role in the directionality, rather than the amount, of axonal growth. This is consistent 366 
with the effect of other axon attractants acting via similar mechanisms. For example, short-term 367 
exposure of axonal growth cones to gradients of BDNF stimulates IP3-induced Ca2+ release (IICR) 368 
that causes axonal attraction without an overall effect on neurite extension (Li et al., 2005).  369 
One interesting observation from this project was the fasciculation of neurites in response to 370 
soluble Lasso/TEN2 (Figure 5C, F). Fasciculation of axons is one of the major mechanisms of 371 
axonal navigation, for example in limb development (Bastiani et al., 1986). While axonal 372 
fasciculation has not been previously linked to a soluble ECD of TEN, neurite bundling was 373 
actually observed in hippocampal cultures in response to TEN1 C-terminal peptide (TCAP-1) (Al 374 
Chawaf et al., 2007). Furthermore, knockdown of TEN1 in C. elegans resulted in de-fasciculation 375 
of the axons in the ventral nerve cord (Drabikowski et al., 2005). Potential mechanisms of axonal 376 
bundling include actin reorganization induced by an LPHN1-mediated rise in cytosolic Ca2+, other 377 
unknown interactions with cell adhesion molecules, or it could also be due to the divalent 378 
Lasso/TEN2 fragment crosslinking adjacent axons, thus promoting their parallel elongation. 379 
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The soluble Lasso/TEN2 fragment could potentially have two membrane-anchored receptors: (i) 380 
TEN2 itself, as a homophilic ligand (Bagutti et al., 2003; Rubin et al., 2002), or (ii) LPHN1, as a 381 
heterophilic ligand (Boucard et al., 2014; Silva et al., 2011). However, we have not observed 382 
TEN2 expression in growth cones of hippocampal axons (Figure 1E), but found it to be abundant 383 
on dendrites (Silva et al., 2011) (Figure 1E, S1B). We also did not detect any appreciable binding 384 
of the released Lasso ECD to membrane-anchored Lasso (Figure 2D, Figure 2²supplement 1, 385 
B). In addition, homophilic interaction of Lasso/TEN2 actually has been reported to inhibit neurite 386 
outgrowth in neuroblastoma cells (Beckmann et al., 2013), while we saw an opposite effect (Figs. 387 
4, 5). Thus, the potential Lasso/TEN2 homophilic interaction could not explain the observed 388 
axonal attraction. On the other hand, we found strong expression of LPHN1 on the axonal growth 389 
cones of cultured hippocampal neurons (Figure 1E-I, S1C-F) (Silva et al., 2011). Importantly, the 390 
released soluble ECD of Lasso strongly bound to LPHN1 that was expressed on neuroblastoma 391 
cells or neuronal growth cones (Figure 2, Figure 2²supplements 1-2). Furthermore, we found 392 
that deletion of LPHN1 precluded axonal attraction by Lasso (Figure 4), while it had no effect on 393 
neuronal cell bodies and dendrites in the Somal Compartment. These data strongly implicate 394 
LPHN1 in mediating Lasso-induced axon attraction. 395 
Our studies also reveal the likely mechanism that underlies the Lasso/LPHN1-induced axonal 396 
attraction. LPHN1 is a G-protein-coupled receptor (GPCR) that physically and functionally links 397 
to *Įq/11 (Rahman et al., 1999). Activation of LPHN1 by its non-pore-forming agonist, LTXN4C, 398 
leads to aggregation of the NTF and CTF of LPHN1 (Silva et al., 2009; Volynski et al., 2004). This 399 
results in assembly of a functional GPCR, with subsequent activation of the downstream signaling 400 
cascade, which includes *Įq/11, phospholipase C, production of IP3 and IP3-receptor-mediated 401 
release of Ca2+ from intracellular stores (Capogna et al., 2003; Lajus et al., 2006; Volynski et al., 402 
2004), thus inducing IICR.  403 
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IICR is also regulated and enhanced by increased cAMP levels (Tojima et al., 2011), and we 404 
previously demonstrated that activation of LPHN1 expressed in COS7 cells induces an increase 405 
in cAMP production (Lelianova et al., 1997). In line with this, the recent study by Li et al. (2018) 406 
confirmed the ability of LPHN1 to regulate cAMP signaling. In that work (Li et al., 2018), the cAMP 407 
signaling interference system was based on HEK293 cells expressing exogenous ȕ2 408 
DGUHQRFHSWRUȕ$5Activation RIȕ$5E\LWVDJRQLVW led to an increase in cAMP production, 409 
while a large excess of co-expressed LPHN1 LQWHUIHUHGZLWKȕ$5VLJnaling. This clearly suggests 410 
that /3+1XVHVWKHVDPHF$03VLJQDOLQJPDFKLQHU\DVȕ$5, and that when LPHN1 is not 411 
stimulated, it can titrate components of this machinery, decreasing their DYDLODELOLW\WRȕ2AR.  412 
In agreement with the role of Lasso as a functional LPHN1 agonist, the binding of the released 413 
Lasso fragment to LPHN1 similarly causes the re-association of LPHN1 fragments (Figure 6) and 414 
Ca2+ signaling (Figure 7A-C). A rise in cytosolic Ca2+ concentration, in turn, can increase the rate 415 
of exocytosis, and we indeed observed enhanced acetylcholine release in mouse neuromuscular 416 
junctions in response to soluble Lasso (Figure 7D-F). This response to Lasso was clearly 417 
mediated by LPHN1, as it was not detected in neuromuscular preparations from LPHN1 KO mice 418 
(Figure 7D-F). On the other hand, the effect of soluble Lasso on vesicular exocytosis was much 419 
weaker ± and probably more physiological ± than the massive effect of LTXN4C.  420 
In addition to Ca2+ regulation, Lasso binding to LPHN1 can induce cAMP signaling. Indirect 421 
evidence for this is provided by the cAMP signaling interference experiments mentioned above 422 
(Li et al., 2018). When LPHN1 co-H[SUHVVHG ZLWK ȕ2AR was stimulated for 24 hours with 423 
Lasso/TEN2 (expressed on the same or opposite cells), this strongly decreased cAMP levels 424 
LQGXFHG E\ ȕ2AR activation. The most likely reason could be that following an initial Lasso-425 
induced LPHN1 activation, which normally subsides within 30 min (Figure 7B), the continued 426 
LPHN1 stimulation led to massive heterologous receptor desensitization (Kelly et al., 2008).  427 
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Intriguingly, the effects of soluble Lasso resemble the well-known mechanism that underpins 428 
axonal attraction and consists of IP3 receptor-mediated local release of Ca2+ from intracellular 429 
stores, coupled with an increase in cAMP levels, that leads to increased exocytosis at the 430 
advancing edge of a growth cone (Akiyama et al., 2009; Qu et al., 2002; Tojima et al., 2011; 431 
Tojima and Kamiguchi, 2015). Thus, when a gradient of soluble Lasso ECD approaches one side 432 
of an axonal growth cone, it may cause local activation of LPHN1 and its downstream signaling, 433 
ultimately leading to IICR. Local IICR in growth cones can induce an increase in vesicular 434 
exocytosis (as observed in our experiments with Lasso-G, Figure 7) and the remodeling of actin 435 
filaments (Tojima et al., 2011). The resulting augmented membrane delivery and actin-driven 436 
extension of filopodia at the edge facing a Lasso gradient ZRXOG VXSSRUW WKH JURZWK FRQH¶V437 
advance in this direction. Thus, based on all our data, we propose this chain of events 438 
(summarized in Figure 8) as a likely mechanism for axonal attraction by soluble Lasso observed 439 
in this study.  440 
While TEN2 has been implicated in axon guidance in the visual pathway (Young et al., 2013), 441 
here we report that it can also trigger axonal steering in developing hippocampal neurons, which 442 
is consistent with the strong expression of both Lasso/TEN2 and LPHN1 in the hippocampus 443 
(Davletov et al., 1998; Otaki and Firestein, 1999). Furthermore, both proteins are expressed 444 
throughout the CNS, suggesting that this mechanism of soluble Lasso/LPHN1-mediated axonal 445 
attraction may apply widely across the brain, especially in such areas as the cortex, cerebellum, 446 
thalamus and spinal cord.  447 
Interestingly, the splice variant of TEN2 (TEN2+SS), which contains the 7-amino acid insert in the 448 
ȕ-propeller domain and cannot mediate cell adhesion via LPHN1 (Li et al., 2018), might attract 449 
dendrites instead of axons, in contrast to Lasso (TEN2-SS). Thus, in an artificial synapse 450 
formation experiment (Li et al., 2018), HEK293 cells expressing TEN2+SS were seen covered by 451 
neurites from co-cultured hippocampal neurons that contained GABAA receptors. However, these 452 
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processes did not show a proportionate amount of PSD-95 and thus probably represented en 453 
passant dendrites that were attracted to TEN2+SS cells, but unable to form mature inhibitory 454 
synapses with them. This could be a mechanism by which TEN2+SS could provide a substrate 455 
for the growth of dendrites searching for their ultimate target/s. Although the relative abundance 456 
of Lasso and TEN2+SS in the brain is unknown, these data suggest that various TEN isoforms 457 
could participate in distinct interactions, possibly with opposite results. 458 
High expression of LPHN1 and Lasso/TEN2 throughout the CNS, combined with their 459 
fundamental role in axon guidance, is consistent with lethal phenotypes observed in simpler 460 
organisms (Langenhan et al., 2009; Mosca et al., 2012). In knockout mice, however, the 461 
phenotype is less severe (Tobaben et al., 2002; Young et al., 2013) (Ushkaryov, to be published 462 
elsewhere) suggesting that LPHN1 deletion is not completely penetrant, likely due to a 463 
compensatory effect of multiple LPHN and TEN homologs expressed in the mammalian brain. 464 
Indeed, LPHN1 can also weakly interact with TEN4 (Boucard et al., 2014), and LPHN3 can 465 
interact with TEN1 (O'Sullivan et al., 2014). Moreover, LPHN and TEN isoform expression 466 
patterns overlap (Oohashi et al., 1999; Sugita et al., 1998; Zhou et al., 2003). This predisposition 467 
to compensation further raises the possibility that the mechanism of axonal guidance involving 468 
the interaction of soluble TEN2 with LPHN1, described in this study, may occur between different 469 
members of the LPHN and TEN families. These observations provide evidence of further diversity 470 
of interactions and local specificity of developmental pathways for more accurate and plastic 471 
patterning of neural networks within the mammalian CNS. 472 
MATERIALS AND METHODS 473 





Designation Source or Reference Identifiers Additional information 
Antibody Anti-FLAG M2 affinity gel Sigma-Aldrich A2220  
Antibody Chicken anti-myc Millipore AB3252 RRID:AB_2235702 
(Immunocytochemist
ry 1:1,000) 
Antibody Mouse anti-actinin Sigma-Aldrich A7811 (Western blot 1:1,500) 







(Silva et al., 2011) dmAb 
TN2C 
(Immunocytochemist
ry 1:300; Western 
blot 1:1,000) 
Antibody Mouse anti-MAP-2 Neuromics MO22116 (Immunocytochemist
ry 1:1,000) 











ry 1:1000; Western 
blot 1:) 
Antibody Mouse monoclonal 









Antibody Rabbit anti-NF-H Neuromics RA22116 
(Immunocytochemist
ry 1:1,000; Western 
blot 1:10,000) 
Antibody Rabbit anti-PSD-95 Millipore AB9708 RRID:AB_11212529 
(Immunocytochemist
ry 1:2,000) 
Antibody Rabbit anti-Tau Synaptic Systems 314 002 RRID:AB_993042 
(Immunocytochemist
ry 1:1,000) 





Antibody Rabbit polyclonal 
anti-LPHN1 NTF (Davletov et al., 1998) RL1 
(Immunocytochemist
ry 1:1,000) 
Antibody Rabbit polyclonal 
anti-LPHN1-peptide (Davydov et al., 2009) PAL1 
(Immunocytochemist
ry; Western blot 3 
ng/mL) 
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Scientific A23016  
Chemical 
compound Vybrant DiO 
Thermo Fisher 
Scientific V22886  
Commercial 
assay or kit 
Amaxa Rat Neuron 
Nucleofector Kit Lonza VAPG-1003  
Commercial 





























DNA reagent Lasso-A (Silva et al., 2011) GenBank: JF784341  
Recombinant 
DNA reagent Lasso-D (Silva et al., 2011) GenBank: JF784344  
Recombinant 
DNA reagent Lasso-FS (Silva et al., 2011) GenBank: JF784340  
Recombinant 
DNA reagent Lasso-G (Silva et al., 2011) GenBank: JF784347 GST-Lasso 
Recombinant 







Scientific K4938-00  
Recombinant 
DNA reagent 
Primer: N255: Neo 
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LTXN4C (Volynski et al., 2003) N/A  
Software AxoScope 10 Axon Instruments   








Microimaging GmbH LSM 510  
Software 
LSM Image Browser 
(for image archiving 
and measurements) 
Carl Zeiss 
Microimaging GmbH RRID:SCR_014344  
Software MATLAB Mathworks RRID:SCR_001622  
Software MiniAnalysis Synaptosoft   
Software 
Volocity (for image 
acquisition and 
stitching) 
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hippocampus BrainBits UK Rhp  
Chemical reagents 475 
All chemicals and reagents were purchased from Sigma-Aldrich, unless otherwise stated. Cell 476 
culture reagents were from PAA Laboratories or Thermo Fisher Scientific. Purified proteins: 477 
LTXN4C (Volynski et al., 2003); LTXN4C labeled with Alexa Fluor 647 (Volynski et al., 2004); Lasso-478 
G (Silva et al., 2011); Lasso-D (Silva et al., 2011) (all prepared in this laboratory); human BDNF 479 
(R&D Systems, 248-BD); BSA-TRITC (Thermo Fisher Scientific, A23016). 480 
Antibodies 481 
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The following antibodies were used in this work: Rabbit anti-NF-H (Neuromics, RA22116); mouse 482 
anti-MAP-2 (Neuromics, MO22116); mouse monoclonal anti-V5 (clone SV5-Pk1, AbD 483 
Serotec/Bio-Rad, MCA1360); rabbit anti-V5 (Thermo Fisher Scientific, PA1-29324; 484 
RRID:AB_1961277); mouse monoclonal anti-myc (clone 9E10, Millipore, 05-419; 485 
RRID:AB_309725); chicken anti-myc (Millipore , AB3252; RRID:AB_2235702); mouse anti-FLAG 486 
M2 (Sigma-Aldrich, F3165; RRID:AB_259529); anti-FLAG M2 affinity gel (Sigma-Aldrich, A2220); 487 
mouse anti-actinin (Sigma-Aldrich, A7811); rabbit polyclonal anti-LPHN1-peptide (PAL1, 488 
(Davydov et al., 2009); rabbit polyclonal anti-LPHN1 NTF (RL1) (Davletov et al., 1998); mouse 489 
anti-Lasso/TEN2 C-terminus (TN2C, dmAb) (Silva et al., 2011); sheep anti-TEN2 N-terminus 490 
(TN2N, R&D systems, AF4578; RRID:AB_10719438); mouse anti-synapsin (Santa-Cruz 491 
Biotechnology, sc-376623; RRID:AB_11150313); rabbit anti-PSD-95 (Millipore, AB9708; 492 
RRID:AB_11212529); rabbit anti-Tau (Synaptic Systems, 314 002; RRID:AB_993042); rabbit 493 
anti-GFP (Thermo Fisher Scientific, A-11122; RRID: AB_221569).  494 
Cell lines 495 
The following cell lines were used: human embryonic kidney cells (HEK293A, purchased from 496 
ECCC; RRID:CVCL_6910); mouse neuroblastoma cells (NB2a, a kind gift from Dr. C. Isaac, 497 
Imperial College London; originally from ATCC and subsequently authenticated by ATCC using 498 
their proprietary methods.; RRID:CVCL_0470). Both cultures are mycoplasma-free, based on a 499 
mycoplasma test kit PlasmoTest (Invivogen). 500 
Animals and biological samples 501 
A LPHN1 KO mouse (strain AG148-2, Adgrl1-/-) was generated on the 129SvJ genetic 502 
background. Briefly (details to be published elsewhere), the LPHN1 gene was isolated from a 503 
BAC clone containing a 36-kbp fragment of mouse genomic DNA. This was used to design a 504 
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transfer vector for homologous recombination, containing a 13-kbp gene fragment of the LPHN1 505 
gene, in which the intron between exons 1 and 2 was replaced with a neomycin gene/promoter 506 
cassette flanked by two loxP sequences. This insert disrupted the open reading frame in the 507 
mRNA transcribed from the resulting mutated LPHN1 gene. The transfer vector, carrying also a 508 
negative selection marker (diphtheria toxin A-chain), was used to generate stably transfected 509 
129Sv/J ES cell lines and chimeric mice, using standard transgenic techniques. Mice transmitting 510 
the inactivated LPHN1 gene through the germline were selected, inbred, back-crossed onto 511 
C57BL/6J background, and maintained at Charles River UK. LPHN1 gene disruption was 512 
confirmed by Southern blotting, PCR amplification using multiple primer pairs and Western 513 
blotting. The genotype of all animals used for breeding and tissue extraction was determined by 514 
PCR. All procedures (breeding and Schedule 1) were approved by the University of Kent Animal 515 
Welfare Committee and performed in accordance with Home Office regulations and the European 516 
Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific 517 
Purposes.  518 
E18 hippocampi were obtained from rats (BrainBits UK, Rhp). P0 hippocampi were prepared from 519 
P0 mice (strains: C57BL/6J, Adgrl1+/+, LPHN1 WT or AG148/2, Adgrl1-/-, LPHN1 KO). Flexor 520 
digitorum brevis muscle preparations were isolated from P21 male mice (C57BL/6J or AG148/2). 521 
Molecular biology reagents 522 
The sequences of human Lasso (Ten±2) mutants used in this study are available at GenBank: 523 
Lasso-FS (JF784340), Lasso-A (JF784341), Lasso-D (JF784344), GST-Lasso (JF784347). N- 524 
and C-terminally tagged rat LPHN1 (termed also LPH-42, MF966512) was described previously 525 
as V5-LPH-A (Volynski et al., 2004). All cDNAs were subcloned into the pcDNA3.1 vector 526 
(Thermo Fisher Scientific). A negative control plasmid, pLenti6.2-GW/EmGFP-miR (Thermo 527 
Fisher Scientific, K4938-00), was used for GFP expression, and the miRNA oligonucleotides listed 528 
below were cloned into this vector for LPHN1 knock-down experiments.  529 
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Oligonucleotides for targeting LPHN1 mRNA were: LPHN1miR14T, (TGCTGATAAAC 530 
AGAGCGCAGCACATAGTTTTGGCCACTGACTGACTATGTGCTGCTCTGTTTAT) and 531 
LPHN1miR14B (CCTGATAAACAGAGCAGCACATAGTCAGTCAGTGGCCAAAACTATGTGCT 532 
GCGCTCTGTTTATC). PCR primers for genotype analysis were: Neo Forward (N255, 533 
CGAGACTAGTGAGACGTGCTACTTCCATTTGTC); LPHN1 Forward (N425, CTGACCCATA 534 
ACCTCCAAGATGATGTTTAC); Neo/LPHN1 Reverse (N424, GATCTTGTCA 535 
TCTGTGCGCCCGTA). 536 
Generation of stable cell lines 537 
Human embryonic kidney (HEK293A) and rat neuroblastoma (NB2a) cell lines were cultured 538 
using standard techniques in DMEM with 10% heat-inactivated fetal bovine serum (FBS, PAA 539 
Laboratories), at 5% CO2 and 37 °C. Stable cell lines were generated using the Escort III 540 
transfection reagent and Geneticin selection (Thermo Fisher Scientific). The positive cells were 541 
further enriched by fluorescence-assisted cell sorting (BD Biosciences). All NB2a cell cultures 542 
contain proliferating, spindle-like cells and differentiated, neuron-like cells. We have not observed 543 
any difference in Lasso or LPHN1 expression between these two types of cell in stably transfected 544 
NB2a cultures.  545 
Protein purification 546 
For increased expression of Lasso or LPH constructs, the complete medium was replaced with a 547 
serum-free DMEM (for HEK23A cells) or Neurobasal-A containing supplements (for NB2a cells). 548 
Lasso-D was purified by immunoaffinity chromatography. Briefly, serum-free medium conditioned 549 
by HEK293A cells expressing Lasso-D was filtered through 0.2 µm filters and incubated with anti-550 
FLAG M2 affinity gel overnight at 4 °C. Lasso-D was then eluted with 20 mM triethylamine, 551 
neutralized with 1 M HEPES, dialyzed against PBS, sterile-filtered for use in cell culture and 552 
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concentrated on sterile 30 kDa MWCO filtration units (Vivaspin, GE Lifesciences). Medium above 553 
non-transfected cells was processed in the same manner and used as a negative control. Amount 554 
and purity of concentrated Lasso-D were assessed by SDS-PAGE and Coomassie staining. 555 
Activity was confirmed by measuring its binding to cell-surface or soluble LPHN1 constructs (Silva 556 
et al., 2011). 557 
Primary neuronal cultures 558 
Hippocampal cultures were prepared from Sprague-Dawley E18 rat hippocampi (BrainBits UK), 559 
according to the supSOLHU¶V LQVWUXFWLRQV RU GLVVHFWHG IURP3$*PRXVHSXSV Adgrl1-/-, 560 
LPH1 KO) under sterile conditions. Hippocampi were digested with 2 mg/ml papain in Ca2+-free 561 
Hibernate-A medium and dissociated in Hibernate-A medium with B27 supplement using fire-562 
polished Pasteur pipettes. Cells were seeded in Neurobasal-A/B27 medium on poly-D-lysine-563 
coated 13-mm coverslips at 5 x 104 cells/coverslip and maintained at 5 % CO2 and 37 ºC. The 564 
medium was partially replaced at least once a week. 565 
Electroporation of neurons 566 
Primary hippocampal neurons were transfected using Amaxa Rat Neuron Nucleofector Kit 567 
(Lonza) as described by the manufacturer. Briefly, dissociated cells were resuspended in Rat 568 
Neuron Neucleofector Solution with Supplement, then mixed with 3 µg of pcDNA6-GFP and 569 
electroporated in Nucleofector using the G-013 program. The transfected cells were resuspended 570 
in 500 µl of a recovery medium, containing a 1:3 mixture of Hibernate-A/B27 and Ca-free 571 
Hibernate-A (BrainBits UK), and incubated at 37 °C for 15 min. Cells were plated at a higher 572 
concentration to compensate for cell death. Next day, 0.8 nM Lasso-D was added to the medium 573 
(PBS was added to control medium). At 4 DIV, the cultured hippocampal cells were fixed with 4% 574 
paraformaldehyde (PFA), stained and visualized as described below in Image Analysis. 575 
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Cultures in MAIDs 576 
To investigate axonal responses to chemoattractant gradients, MAIDs (Figure 5) with 150 µm 577 
VHSDUDWLRQZDOOV;RQD0LFURIOXLGLFV//&ZHUHSUHSDUHGLQDFFRUGDQFHZLWKWKHPDQXIDFWXUHU¶V578 
guidelines (Harris et al., 2007a; Harris et al., 2007b). Briefly, MAIDs were sterilized with ethanol, 579 
washed with sterile water and dried. To facilitate firm attachment of MAIDs, 22 x 22 mm coverslips 580 
(VWR International) were sonicated in water and ethanol, autoclaved, dried, then coated with 1 581 
mg/ml poly-D-lysine overnight, washed, and dried overnight before the assembly. 582 
For neuronal cell culture in MAIDs, E18 rat hippocampi were dissociated as above. Neurons (1.5 583 
x 105/10 µl) were added to Somal Compartments and allowed to settle for 30 min. MAIDs were 584 
then filled with Neurobasal-A/B27. After 3 DIV, the medium in Axonal Compartments was carefully 585 
replaced with medium containing soluble Lasso-D or with control medium. Alternatively, 586 
HEK293A cells stably expressing Lasso-D (or untransfected) were plated in the wells of Axonal 587 
Compartment. At 8 DIV, the cells were fixed and processed as described below. 588 
Protein diffusion in MAIDs 589 
For diffusion modeling experiments, MAIDs were assembled as above and filled with PBS; then 590 
0.1 mg/ml BSA-TRITC (Thermo Fisher Scientific) in PBS was added to Axonal Compartments 591 
without changing liquid level in any compartment (to avoid creating a hydrostatic pressure in the 592 
microchannels). BSA-TRITC diffusion in MAIDs was monitored by time-lapse fluorescent imaging 593 
of all compartments for 5 days under an Axiovert fluorescent microscope (Carl Zeiss) equipped 594 
with a temperature- and humidity-controlling enclosure, and a Canon G5 camera. Fluorescence 595 
intensity profiles across the microchannels at multiple time points were generated in ImageJ 596 
NIMH, Bethesda; RRID:SCR_002285, RRID:SCR_003070) and normalized to the fluorescence 597 
profile of 100 ng/ml BSA-TRITC forced into the microchannels and both compartments. 598 
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Immunocytochemistry 599 
Cells on coverslips or inside MAIDs were fixed for 10 min with 4% PFA (for staining requiring SDS 600 
treatment to aid epitope retrieval, the fixative also included 0.1 % glutaraldehyde). Cells were 601 
permeabilized with 0.1 % Triton X-100 (or 1% SDS for PAL1 and dmAb staining), washed, then 602 
blocked for 1 h with 10 % goat serum in PBS and incubated with primary antibodies in blocking 603 
solution (dilutions used were: PAL1, 3 ng/ml; dmAb, 1:300; anti-NF-H, anti-myc mAb, and anti-604 
GFP, 1:1,000; anti-V5, 1:2,000) for 1 h at room temperature (or overnight at 4 °C with PAL1 and 605 
dmAb). The coverslips or MAIDs were then washed 3 times and incubated for 1 h with secondary 606 
antibodies in blocking solution, followed by 3 washes. Coverslips were mounted using FluorSave 607 
mounting medium (Calbiochem), while neurons in MAIDs were imaged within 4 hours after the 608 
washes. 609 
Receptor patching 610 
NB2a cells stably expressing LPH-42 were grown on poly-D-lysine-coated coverslips in DMEM, 611 
10 % fetal calf serum (PAA Laboratories) to 30±50% confluency and to test receptor clumping 612 
incubated at 0 °C for 20 min in PBS with one of the 3 potential LPHN1 ligands: (1) 20 nM Lasso-613 
D, (2) 2 nM Alexa Fluor 647-labeled LTXN4C (Volynski et al., 2004), or (3) rabbit anti-NTF 614 
antibodies (RL1), followed by a 20-min incubation with Alexa Fluor 546-conjugated goat anti-615 
rabbit IgG. In control, only the fluorescent secondary antibody was added for the last 20 min. The 616 
cells were then fixed for 10 min with 4 % PFA in PBS, blocked with 10 % goat serum in PBS, and 617 
subsequent procedures were designed to reveal the distribution of the three components of each 618 
assay (NTF, CTF, and ligand). First, in all experiments, the V5 epitope on LPHN1 NTF was 619 
detected with a rabbit anti-V5 antibody (1 h in blocking solution), followed by Alexa Fluor 488-620 
conjugated goat anti-rabbit IgG and fixation. Subsequent staining depended on the ligand used: 621 
(1) Lasso-D was stained using a mouse anti-FLAG mAb and Alexa Fluor 546-conjugated goat 622 
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anti-mouse IgG. For LPHN1 CTF detection, the cells were then permeabilized with 0.1 % Triton 623 
X-100, incubated with a chicken anti-myc antibody, fixed, blocked, and stained with Alexa Fluor 624 
647-conjugated anti-chicken antibody. (2) With LTXN4C-induced patching, the cells were 625 
permeabilized, incubated with a mouse anti-myc mAb, fixed, blocked, and stained with an Alexa 626 
Fluor 546-conjugated anti-mouse IgG. (3) With RL1-induced patching (and in controls), the cells 627 
were permeabilized, incubated with the chicken anti-myc antibody, fixed, blocked, and stained 628 
with Alexa Fluor 647-conjugated anti-chicken antibody. The primary antibodies were used at 629 
1:1000 dilution; the secondary antibodies, 1:2000; the cells were washed 3 times with PBS after 630 
each stage. At the end, the cells were briefly fixed, blocked, washed, and mounted using 631 
FluorSave reagent (Calbiochem, Cat. No. 345789).  632 
Image acquisition 633 
Images of axons in MAIDs were acquired on an Axiovert 200M microscope (Carl Zeiss) using LD 634 
Plan-Neofluar 20x objective and Volocity-controlled camera, filters, shutter, and stage. Images 635 
were taken with a 5 % overlap to facilitate stitching (Perkin-Elmer; RRID:SCR_002668). Blank 636 
images were subtracted to correct for optical artifacts. The images were stitched automatically 637 
DQG³GHVSHFNOHG´XVLQJD[PHGLDQILOWHU,PDJH-7RFRUUHFWIRUODUJHLOOXPLQDWLon artifacts, 638 
EDFNJURXQGZDVVXEWUDFWHGLQ,PDJH-XVLQJWKH³6XEWUDFWEDFNJURXQG´SOXJ-in, with a 100-µm 639 
window and the sliding paraboloid algorithm. 640 
Images of immunostained cells and neurons on coverslips (other than for neurite tracing) were 641 
acquired using an upright laser-scanning confocal microscope (LSM-510, Zeiss; 642 
RRID:SCR_014344) equipped with 40x or 100x oil-immersion objectives; 488, 543, and 633 nm 643 
lasers; and 505±530, 560±615, and >650 nm emission filters. Images for neurite tracing were 644 
acquired using Axio Observer.Z1 microscope (Zeiss) equipped with Hamamatsu ORCA-Flash 4 645 
sCMOS camera, EC Plan-Neofluar 40x objective, Colibri 2 LED illumination and appropriate 646 
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filters. 647 
Image analysis 648 
To correlate the polarity of LPH1 expression and growth cone turning, GFP images of growth 649 
cones and preceding axons were traced using CorelTRACE X3 (Corel, Canada). The obtained 650 
contour images were aligned along their median line, with all axons starting at the same point. 651 
The images were then flipped so that the higher LPHN1 staining was located in the right half of 652 
each growth cone. The trajectory of respective axons was then assessed: correlation was 653 
considered positive if the axon approached its cone from the right quadrant. To plot Jeffreys 654 
confidence intervals (CI) for a binomial distribution the standard formula was used: CI = 655 
p+z*sqrt(p*(1-p)/n), where z = 3 for confidence level CI = 0.9973.  656 
For profiling of neurite growth within MAID Axonal Compartments, regions of interest 657 
encompassing the depth of the compartments, were selected, avoiding artefacts (e.g. antibody 658 
aggregates or HEK cell bodies). The average fluorescence was determined as a function of 659 
distance (see Fig 5A) from the separation wall and binned over 100 µm intervals. Background 660 
fluorescence in the areas beyond 1200 µm from the wall (that contained no axons) was subtracted 661 
from all other fluorescence values, and the results were used for statistical analysis as described 662 
below. 663 
For axon fasciculation measurements in MAIDs, the width of each axon/bundle was determined 664 
in pixels at 100 µm from the separation wall and converted to µm.  665 
Neurite tracing of GFP-positive neurons was performed in ImageJ (Schindelin et al., 2012) using 666 
default settings in Simple Neurite Tracer plug-in (Longair et al., 2011). The longest neurite for 667 
each cell was used as a single independent measurement (data obtained from three independent 668 
cultures). 669 
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Analysis of the co-localization of the NTF, CTF, and respective ligands in the plasma membrane 670 
was carried out using a method previously developed and tested (Silva et al., 2011). Here, the 671 
confocal images were obtained near the middle of each cell (optical plane, Z    ȝP )RU672 
consistency, the recorded images were assigned false colors according to the detected protein, 673 
irrespective of the actual fluorescence wavelength used for detection. The fluorescence profiles 674 
IRUHDFKSURWHLQDORQJ WKHFHOO¶VSHULPHWHUZHUHFROOHFWHGXVLQJ ,PDJH-3HDUVRQ¶VFRUUHODWLRQ675 
coefficient r was then calculated for the pairs of resulting profiles obtained from 4-7 independent 676 
experiments.  677 
In the representative images that were used in the Figures, the contrast and brightness were 678 
enhanced in the same manner as in respective control images.  679 
Fluorometry 680 
For experiments with LPHN1 KO and WT/HET cultures in MAIDs, the membranes of cell bodies 681 
and axons were labeled using 5 µM DiO (Vybrant® DiO, Life Technologies) in Neurobasal-A, 682 
containing B-27 supplement and 0.005% Pluronic F-127 (Sigma-Aldrich), which had been passed 683 
through a 0.2 µm filter. After 30 min incubation, the excess dye was carefully washed 2 times, 684 
and the cell bodies (Somal Compartments) and axons (Axonal Compartments) were solubilized 685 
in 1% Triton X-100 in PBS. The undiluted axonal and 10-fold diluted somal fractions were 686 
analyzed in microtiter plates using a Fluoroskan Ascent Fluorometer (485 nm excitation, 505 nm 687 
emission filters) (Thermo Fisher Scientific). In some experiments, ȝ/samples of lysates were 688 
individually measured using a NanoDrop ND-3300 Fluorospectrometer (Thermo Fisher Scientific) 689 
with the following settings: 470 nm Blue LED excitation, 500-700 nm emission spectrum, 690 
quantified at 504 nm. The levels of fluorescence were proportional to the amount of axons/cells 691 
bodies present in respective compartments. 692 
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Western blotting 693 
For Western Blot analysis of conditioned media, these were passed through 0.2 µm low protein-694 
binding filters (PALL, USA). The cells on coverslips were lysed in ice-cold RIPA buffer (1 % 695 
sodium deoxycholate, 0.1 % SDS, 1 % Triton X-100; 10 mM Tris-HCl, pH 8; 140 mM NaCl), 696 
supplemented with protease inhibitors and 1 mM EDTA. To prepare samples for electrophoresis, 697 
the cell lysates and media were incubated at 50 °C for 30 min with sample buffer  containing 2% 698 
SDS and 100 mM DTT. The samples were separated on standard SDS-containing polyacrylamide 699 
gels, blotted onto polyvinylidene fluoride membrane (Immobilon-P, IPVH00010, Merck), 700 
incubated with primary antibodies diluted in 2 % BSA for TN2N or 5% milk for all other antibodies 701 
(dilutions used were: PAL1, 1:500; dmAb, 1:1,000; TN2N, 1 µg/ml; actinin, 1:1,500; NF-H, 702 
1:10,000) and respective horseradish-peroxidase conjugated secondary antibodies. The stained 703 
membranes were visualized by WestFemto chemiluminescent substrate kit (Thermo Fisher 704 
Scientific) and LAS3000 gel/blot documentation system (FUJIFILM). 705 
Measurements of cytosolic Ca2+ 706 
Cytosolic Ca2+ concentration was monitored using Fluo-4 Ca2+ indicator (the method was also 707 
described in (Silva et al., 2009; Volynski et al., 2004). The stably transfected NB2a cells 708 
expressing LPH-42 were pre-incubated in serum-free medium for 24 h in 30 mm dishes. Then the 709 
cells were equilibrated for 20 min in physiological buffer (in mM: NaCl, 145; KCl, 5.6; glucose, 5.6; 710 
MgCl2, 1; EGTA, 0.2; HEPES, 15; pH 7.4; BSA, 0.5 mg/ml) containing 2.5 µM Fluo-4 711 
acetomethoxy ester (Fluo-4-AM, Thermo Fisher Scientific) and 10% Pluronic F±127, washed and 712 
further incubated for 20 min for dye de-esterification. LPHN1-expressing cells were identified by 713 
staining with primary mouse anti-V5 mAb pre-labeled with Alexa Fluor 568 (Zenon, Thermo Fisher 714 
Scientific). Images were acquired every 5 s under the LSM510 microscope using a 40x Achroplan 715 
water-dipping objective, 488 nm laser and a 505±550 nm band-pass emission filter. The following 716 
34 
protocols were typically applied (the addition times and final concentrations of the additives are 717 
indicated, see also Figure 7²figure supplement 1, A and B). Protocol 1: 0 min, baseline recording; 718 
5 min, 1 nM LTXN4C, 360 nM Lasso-D, or control buffer; 30 min, 2 mM Ca2+; 50 min, 1 nM wild-719 
W\SHĮ-LTX; 55 min, end. Protocol 2: 0 min, 2 mM Ca2+, baseline recording; 5 min, 360 nM Lasso-720 
D or control buffer; 30 min, 1 nM LTXN4CPLQQ0Į-LTX; 90 min, end. Ca2+ fluorescence of 721 
individual positive cells was quantified using the LSM510 software and normalized between the 722 
VWDUWLQJIOXRUHVFHQFHDQGPD[LPDOIOXRUHVFHQFHLQGXFHGE\Į-LTX.  723 
Electrophysiology 724 
MEPPs were recorded from isolated neuromuscular preparations by method also used in 725 
(Lelyanova et al., 2009). Flexor digitorum brevis muscles were extracted from male P21 mice 726 
(C57BL/6J: Adgrl1+/+ or Adgrl1-/-), cleaned from connective tissue, fixed using entomological pins 727 
in Petri dishes pre-coated with Sylgard silicone polymer (Dow Corning), and incubated in 728 
constantly oxygenated physiological buffer containing (in mM): NaCl, 137; KCl, 5; MgCl2, 1; 729 
EGTA, 0.2; glucose, 5.6; HEPES, 10; pH 7.5; tetrodotoxin (Latoxan), 0.001). Sharp electrodes 730 
wiWKWLSGLDPHWHUȝPDQG-60 MOhm impedance were produced on a P-97 puller (Sutter) 731 
from borosilicate glass filament capillaries (1.5 mm; World Precision Instruments) and filled with 732 
5 M sodium acetate. Spontaneous presynaptic activity (based on MEPPs detection) was recorded 733 
using a system consisting of an Axoclamp 2B pre-amplifier (Axon Instruments) in the current 734 
clamp mode, a secondary differential amplifier with a high-frequency filter (LPF202A, Warner 735 
Instruments), a HumBug harmonic frequency quencher (Quest Scientific), a Digidata 1322A 736 
digitizer (Axon Instruments), and a microcomputer running AxoScope software (Axon 737 
Instruments). The recorded traces were subsequently analyzed using MiniAnalysis software 738 
(Synaptosoft Inc.). 739 
Quantification and statistical analysis 740 
35 
The data shown are the means ± SEM, unless otherwise stated. A Lilliefors test was applied to 741 
all data sets to assess normality in data distribution. Statistical significance was then determined 742 
using two-tailed heteroscedastic t-test, with Bonferroni correction in cases of multiple pair-wise 743 
comparisons. For non-normally distributed data, a Mann-Whitney test was applied. The axonal 744 
fluorescence curves obtained from image analysis in MAIDs were compared using n-way ANOVA 745 
algorithm (MATLAB; RRID:SCR_001622), where n reflected the number of factors involved in an 746 
assay (treatment type, distance from the separation wall and batch number). To test for correlation 747 
in axonal fasciculation measurements, a Pearson correlation coefficient (R2) and the p values (to 748 
test the correlation hypothesis) were calculated using MATLAB. Jeffreys confidence intervals 749 
were used to assess statistical significance of correlation between LPH1 enrichment and growth 750 
cone turning direction. Differences were considered significant if p < 0.05. The specific p and n 751 
values are indicated in corresponding figure legends or the following notation is used to denote 752 
statistical significance: NS (non-significant), p > 0.05; *, p < 0.05; **, p < 0.01; ***, p < 0.001. The 753 
investigators were blinded to the identity of samples during data collection and analysis in all 754 
experiments involving LPHN1 KO. 755 
Data and software availability 756 
The quantification methods used in the custom scripts are described above. Further requests for 757 
custom scripts and data used in this study should be directed to N.V.V. 758 
(nickolai.vysokov@gmail.com).  759 
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FIGURE LEGENDS 955 
Figure 1 with 1 supplement  956 
Lasso is cleaved and released into the medium during neuronal development. A. 957 
Recombinant Lasso constructs used in this work (FS, full size). The three proteolytic cleavage 958 
sites and the SS splice site are indicated. The antibody recognition sites/epitopes are shown by 959 
bars above the structure. Scale bar, 200 amino acids. B. Intracellular processing and release of 960 
TENs. Left, TEN2 is constitutively cleaved in the trans-Golgi vesicles by furin at site 1. Middle, 961 
when delivered to the cell surface, the ECD remains tethered to the membrane and functions as 962 
a cell-surface receptor. Right, regulated cleavage at site 3 releases the ECD into the medium. C. 963 
Expression of Lasso and release of its ECD fragment in hippocampal neurons in culture. Rat 964 
hippocampal neurons were cultured for 3, 7 and 14 days, and proportionate amounts of the 965 
conditioned media and cell lysates were separated by SDS-PAGE. A Western blot (representative 966 
of three independent experiments, which all gave similar results) was stained for Lasso, LPHN1, 967 
neurofilament-H (NF-H), and actinin. The doublet bands corresponding to splice variants of full-968 
size Lasso (FS) and the fragment of ECD (Frag.) cleaved at site 1 are indicated by arrowheads. 969 
D. Quantification of Western blots (as in C), using Lasso C-terminus staining data. E. Axonal 970 
growth cones (white arrowheads) do not express Lasso/teneurin-2. Neurons in a 9 DIV 971 
hippocampal culture were permeabilized and stained for the axonal protein Tau (green) and Lasso 972 
(TN2C, red) (representative image from n = 5 experiments). F. A detailed study of growth cones. 973 
Hippocampal neurons were transfected with a vector encoding GFP, then, after 14 DIV, stained 974 
for LPHN1 (PAL1 and Alexa 647-conjugated secondary antibody, magenta), and axonal growth 975 
cones were visualized by GFP fluorescence (green). G, H. Correlation of LPHN1 polarization 976 
within a growth cone with its recent travel trajectory. G left, a fluorescent image of a growth cone 977 
stained for LPHN1 (magenta). G right, the same image in false color (contour based on GFP 978 
staining), demonstrating LPHN1 polarization on the right side. H left, the contours of 13 roughly 979 
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symmetrical growth cones and their preceding axons were aligned to locate the stronger LPHN1 980 
staining on the right. Note, that all axons approach growth cones from the right low quadrant. H 981 
right, the proportion of right- and left-turning growth cones plotted with Jeffreys 99.73% 982 
confidence intervals for a binomial parameter; ***, p < 0.001; n = 13. I. LPHN1 is found within 983 
filopodia and lamellipodia on the leading edge (left, arrowheads), but not on the trailing edge 984 
(right) of a growth cone. Green, GFP fluorescence; magenta, PAL1 staining for LPHN1. 985 
Figure 1±figure supplement 1 986 
Lasso is expressed on dendrites and LPHN1 on axonal growth cones in developing 987 
neurons. A. Proportional expression of full-size Lasso and its fragments in hippocampal neurons 988 
in culture. The data are from Western blots (as in Figure 1C, n = 3), stained using the TN2C 989 
antibody. B. Lasso (red) is strongly expressed on dendritic shafts and dendritic growth cones 990 
(black arrowhead). Neurons in 7-9 DIV  hippocampal cultures were stained for Lasso/teneurin-2 991 
using TN2C antibody. C. LPHN1 is expressed in axons and axonal growth cones (white arrow) in 992 
cultured rat hippocampal neurons. 7-9 DIV neuronal cultures were permeabilized and stained for 993 
LPHN1 (green) and synapsin (red). A growth cone is indicated by the white arrow. D. LPHN1 is 994 
enriched in en passant synapses. A 9 DIV hippocampal culture was stained for Lasso (TN2C, 995 
green) and postsynaptic structural protein, PSD-95 (red). Synapses are indicated by asterisks; 996 
the growth cone, by a white arrowhead. E. Knockdown of LPHN1. Hippocampal neurons were 997 
transfected with a bicistronic vector, encoding GFP and an shRNA against LPHN1, then at 14 998 
DIV stained for LPHN1 (magenta) and imaged. Note that the growth cone of a knockdown neuron 999 
(green arrow) lacks LPHN1, while the growth cone of an uninfected neuron (arrowhead) 1000 
expresses LPHN1. F. LPHN1 is expressed near the leading edge of turning growth cones. Left, 1001 
GFP fluorescence of a growth cone. Right, the same growth cone stained for LPHN1 and 1002 
rendered in false color. Note two peaks of LPHN1 quantity (red): in the central region (immediately 1003 
DERYHWKH³QHFN´ LHWKHHQGRID[RQVKDIWDQGQHDUWKHDFWLYHO\JURZLQJVLGHRI WKHJURZWK1004 
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cone. G. An average profile of LPHN1 expression within turning growth cones. LPHN1 1005 
fluorescence was quantified along the median line of turning growth cones, expressed as % of 1006 
maximal fluorescence and plotted against the normalized length of growth cones (distance 1007 
expressed as %). The data are the mean values ± SEM; n = 9. Note the bimodal distribution of 1008 
LPHN1 expression.  1009 
 1010 
Figure 2 with 2 supplements  1011 
Soluble Lasso binds to LPHN1 on other cells. A. A scheme of LPHN and Lasso constructs 1012 
used in this experiment. LPH-82 is LPHN1 with the ECD from another adhesion G-protein-coupled 1013 
receptor, EMR2, used as a negative control. B. Purification of Lasso-D. Lasso-D was expressed 1014 
in stably transfected HEK293 cells, then purified on a column with anti-FLAG Ab and analyzed by 1015 
SDS-PAGE in a 5% gel, stained with Coomassie R250. C-E. Interaction between the soluble 1016 
Lasso species and NB2a cells expressing LPHN1, LPH-82, or Lasso-A. Cells expressing LPHN1 1017 
(C, panels 2, 3), but not Lasso-A or Lasso-FS (D) or mutant LPH-82 (C, panel 4) are able to 1018 
interact with Lasso-D or Lasso-A. E, panel 1. Short-term, high-density incubation of cells 1019 
expressing LPHN1 and membrane-anchored Lasso-A allows these proteins to form inter-cellular 1020 
contacts. E, panel 2. After a 48-h co-culture, a sufficient amount of Lasso-A is released into the 1021 
medium, diffuses away from Lasso-A expressing cells (arrowhead) and can be detected 1022 
interacting with distant LPHN1-expressing cells (arrow). Images are representative of n = 6-7 1023 
independent experiments. 1024 
Figure 2²figure supplement 1 1025 
Soluble Lasso specifically binds to LPHN1-expressing cells. Interaction between the soluble 1026 
Lasso species and NB2a cells expressing LPHN1 or Lasso-A. Cells expressing LPHN1 (A), but 1027 
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not Lasso-A (B), are able to bind the soluble Lasso-D. C. Binding of the soluble Lasso ECD 1028 
released by the cells expressing the full-size Lasso-A to the surface of cells expressing LPHN1, 1029 
after 48 h in co-culture. Note the lack of Lasso-D binding to cells not expressing LPHN1 (A-C) 1030 
and the clumping of both proteins (C). Images are representative of n = 7 independent 1031 
experiments. 1032 
Figure 2²figure supplement 2 1033 
Soluble Lasso specifically binds to LPHN1 on axonal growth cones. Hippocampal neurons 1034 
from LPHN1 WT or KO newborn mice were grown in culture for 14 days and then incubated with 1035 
the medium from NB2a cells stably expressing Lasso-D. The cultures were fixed and stained for 1036 
LPHN1 (PAL1, green) and exogenous Lasso-D (FLAG, red). A. Two examples of LPHN1 WT 1037 
axonal growth cones. B. An example of LPHN KO growth cones. Asterisks, axonal varicosities; 1038 
arrowheads, axonal growth cones. The images are representative of 5-7 independent 1039 
measurements, which all gave similar results. Note that LPHN1 KO neurons do not exhibit LPHN1 1040 
staining (green), only showing autofluorescence, and do not appreciably bind Lasso-D (red). C. 1041 
Quantification of the immunostaining data from n = 3 independent experiments. In control 1042 
H[SHULPHQWVRQO\VHFRQGDU\DQWLERGLHVZHUHXVHG6WXGHQW¶VW-test with Bonferroni correction: *, 1043 
p = 0.031; **, p = 0.009. 1044 
 1045 
Figure 3 1046 
Using MAIDs to study axonal attraction by soluble chemoattractants. A. Left, a photograph 1047 
of a MAID. Center, a scheme of the experiment: neurons are seeded into the Somal Compartment 1048 
and their neurites grow into the Axonal Compartment; both compartments are then stained for 1049 
NF-H (axons) and MAP-2 (dendrites). Right, an enlarged portion of the separating wall showing 1050 
50 
the principles of fluorescence measurements in the Axonal Compartment. B. Fluorescent images 1051 
from the same MAID stained for NF-H (green) and MAP-2 (red) showing that axons penetrate 1052 
into the Axonal Compartment significantly more readily than dendrites. C. Profiles of NF-H and 1053 
MAP-2 fluorescence in the Axonal Compartment, normalized to respective fluorescence in the 1054 
Somal Compartment show that the relative degree of penetration of axons is ~5-fold higher 1055 
compared to dendrites. D. Gradients of soluble proteins can be established within microchannels 1056 
and maintained for several days. Top, a scheme of the experiment: TRITC-conjugated BSA was 1057 
added to the Axonal Compartment and monitored using time-lapse fluorescent microscopy. 1058 
Middle, fluorescence distribution 2 days after TRITC-BSA addition. Bottom, fluorescence 1059 
distribution after filling the whole MAID with TRITC-BSA. E. Quantification of the TRITC-BSA 1060 
gradient within microchannels (normalized to 100 µg/ml TRITC-BSA). The mean values are 1061 
shown ± SEM; n = 4. F-H. A gradient of BDNF in MAIDs acts as an axonal attractant. F. A scheme 1062 
of the experiment. G. Representative images of NF-H-positive axons in the Axonal Compartment 1063 
exposed to control conditions (left) or to a BDNF gradient in the microchannels (right). H. Left, 1064 
Average profiles of normalized NF-H fluorescence in the presence or absence of BDNF (2-way 1065 
ANOVA: **, p = 0.002; F1,84 = 10.15). Right, integrated NF-H fluorescence between 0 and 500 1066 
ȝPIURPWKHVHSDUDWLQJZDOOW-test: *, p = 0.04; n = 5). 1067 
 1068 
Figure 4 with 1 supplement 1069 
A gradient of soluble Lasso-D induces axonal attraction via LPHN1. A. A scheme of the 1070 
experiment: hippocampal neurons were cultured in Somal Compartments, purified Lasso was 1071 
added to Axonal Compartments at 3 DIV. B. Lasso remains intact in the Axonal Compartment. 1072 
The media from Axonal Compartments were collected at 8 DIV and analyzed by Western blotting. 1073 
C. Images of NF-H-positive axons in the Axonal Compartment exposed to control medium (left) 1074 
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or Lasso-D (right). D. Analysis of axonal growth in Axonal Compartments. Left, profiles of NF-H 1075 
immunofluorescence with and without Lasso-D (3-way ANOVA: ***, p < 0.001; F1,144 = 12.92). 1076 
Right, average integrated immunofluorescence at 0- ȝP IURP WKH ZDOO ZLWK DQG ZLWKRXW1077 
Lasso-D (t-test: *, p = 0.027; n = 7). E. Knockout of LPHN1 blocks axonal attraction by soluble 1078 
Lasso. Hippocampal neurons from Adgrl1-/- (LPHN1 KO) and Adgrl1+/+ (LPHN1 WT) mice were 1079 
cultured in MAIDs and exposed to Lasso-D gradient. The amount of cellular material in each 1080 
compartment was quantified by DiO labeling at 8 DIV. E. Left, LPHN1 KO cultures sent 1081 
significantly fewer neurites to Lasso-containing Axonal Compartments compared to WT cultures 1082 
(t-test: ***, p < 0.001, n = 3). Right, there was no difference in the number of cells, dendrites and 1083 
axons in the Somal Compartments between the two types of cultures (t-test: N.S., p = 0.4, n = 3).  1084 
Figure 4²figure supplement 1 1085 
Knockout of LPHN1 prevents axonal attraction by soluble Lasso. A. Experimental 1086 
hypothesis: predicted behavior of LPHN1 KO axons in response to a gradient of soluble Lasso. 1087 
B. Polymerase chain reaction (PCR)-based genotyping of 6 newborn pups from 3 mothers used 1088 
to prepare hippocampal cultures in MAIDs. The PCR primers used and the sizes of amplified 1089 
fragments are shown on the right; the deduced genotypes are indicated at the bottom.  1090 
 1091 
Figure 5 1092 
A spatio-temporal gradient of soluble Lasso induces axonal attraction and fasciculation, 1093 
but does not increase axonal length. A. A scheme of the experiment: HEK293A cells stably 1094 
transfected with Lasso-D were cultured in the wells of Axonal Compartments; untransfected cells 1095 
were used as a control. B. A representative Western blot of the media from Axonal Compartments; 1096 
Lasso-D is secreted by transfected HEK293A cells only and is stable. C. Images of NF-H-positive 1097 
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axons (green) and MAP-2-positive dendrites (red) in the Axonal Compartment exposed to 1098 
temporal gradients formed by control cells (top) or Lasso-D-expressing cells (bottom). D. Left, 1099 
profiles of axons in Axonal Compartments, identified by NF-H immunofluorescence, exposing a 1100 
difference between control and Lasso-secreting cells (3-way ANOVA: **, p = 0.006; n = 7, F1,84 = 1101 
7.89). Right, average integrated axonal fluorescence at 0-ȝPIURPWKHZDOOZLWKFRQWURORU1102 
Lasso-secreting cells (t-test: *, p = 0.045; n = 7). E. Left, profiles of dendrites in Axonal 1103 
Compartments, identified by MAP-2 immunofluorescence, with control or Lasso-secreting cells 1104 
(3-way ANOVA: non-significant, p = 0.23; F1,84 = 1.46). Right, average integrated dendritic 1105 
fluorescence at 0- ȝP IURP WKH ZDOO ZLWK FRQWURO RU /DVVR-secreting cells (t-test: non-1106 
significant, p = 0.54; n = 7). F. Soluble released Lasso-D induces axonal fasciculation. The width 1107 
of all NF-H-positive axonal bundles was measured at 100 µm from the separating wall. The 1108 
GHJUHHRIIDVFLFXODWLRQFRUUHODWHVZLWK/DVVRFRQFHQWUDWLRQ3HDUVRQ¶VFRUUHODWLRQ: R2 = 0.43, p = 1109 
0.041). G. Soluble Lasso has no effect on axon length in cultured hippocampal cells. Left. 1110 
Representative images of GFP-positive neurons immunostained for GAP-43 (red); after treatment 1111 
with control medium (left) or with Lasso-D (right). Right. Quantification of the total neurite length 1112 
in GFP-expressing neurons after the treatment (t-test: non-significant, p > 0.05, n = 30 cells 1113 
without Lasso-D and 61 cells with Lasso-D from 3 independent cultures).  1114 
 1115 
Figure 6 1116 
Interaction of LPHN1 with soluble Lasso causes LPHN1 aggregation. A. A scheme of 1117 
behavior of LPHN1 fragments at rest (left) and after binding an active agonist (middle) or a non-1118 
agonistic antibody (right). B-D. Distribution of NTF and CTF in NB2a cells stably expressing 1119 
LPHN1 and treated with control buffer (B), Lasso-D (C) or LTXN4C (D). E. The binding of a non-1120 
agonistic antibody against NTF of LPHN1 does not cause an association of the NTF and CTF of 1121 
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LPHN1. Images shown are representative of 4 independent experiments (n = 4-7). All scale bars 1122 
DUHLQȝPF. Quantitative analysis of correlation between the ligand-induced redistribution of NTF, 1123 
CTF and ligand. T-test with Bonferroni correction: **, p < 0.01; ***, p < 0.001; n = 4-7 independent 1124 
experiments. 1125 
 1126 
Figure 7 with 1 supplement 1127 
Soluble Lasso induces Ca2+ signaling in LPHN1-expressing cells and enhances 1128 
spontaneous exocytosis at neuromuscular junctions. A. Changes in intracellular Ca2+ 1129 
concentration in neuroblastoma cells stably expressing LPHN1 were monitored using a Ca2+ 1130 
indicator dye, Fluo-4. The scheme of the experiment is shown in Figure 7²figure supplement 1, 1131 
A. After 5 min recording of baseline fluorescence, the cells were treated (maroon arrowhead) with 1132 
control buffer, 1 nM LTXN4C or 360 nM Lasso-D. 20 min later, 2 mM Ca2+ was added (gray 1133 
arrowhead) to synchronize the intracellular Ca2+ signaling, followed by 1 nM wild-W\SHĮ-latrotoxin 1134 
(open arrowhead) to measure Fmax, for normalization. Left, profiles of normalized Fluo-4-Ca2+ 1135 
fluorescence over time for the three conditions used (mean values ±SEM are shown; the data are 1136 
from 80-120 individual cells from n = 4 independent experiments). Right, integration of Fluo-4-1137 
Ca2+ fluorescence over time (from B). Pre-treatment with Lasso-D potentiates intracellular Ca2+ 1138 
signaling. T-test with Bonferroni correction: *, p < 0.05; ***, p < 0.001. B. Experiments testing the 1139 
effect of Lasso-D on the time-course of LTXN4C-induced LPHN1-dependent Ca2+ signaling. Cells 1140 
expressing LPHN1 were loaded with Fluo-4 and stimulated first with control buffer (black 1141 
arrowhead, left) or 1.5 nM Lasso-D (maroon arrowhead, right), and then with 2 nM LTXN4C (blue 1142 
arrowhead). 1 nM wild-type LTX was added at the end (open arrowhead). Ca2+ fluorescence 1143 
measurements were obtained as in A. Representative normalized Ca2+ fluorescence profiles are 1144 
shown. C. Time delay before the onset of LTXN4C-induced signaling in cells pretreated with control 1145 
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buffer or Lasso-D determined from traces in B. T-test: *, p < 0.05; the data are from 166 buffer-1146 
LTXN4C-treated cells and from 144 Lasso-LTXN4C-treated cells, from n = 5 independent 1147 
experiments. D. Representative raw recordings of MEPPs in neuromuscular preparations from 1148 
LPHN1 WT and KO mice, in buffer containing 2 mM Ca2+ without any agonists or in the presence 1149 
of 20 nM Lasso-G or 1 nM LTXN4C. E. The frequency of MEPPs in the absence or presence of 20 1150 
nM Lasso-G, as in D. Left, Lasso-G significantly increases the frequency of MEPPs at 1151 
neuromuscular junctions from WT mice, but has no effect on exocytosis in LPHN1 KO synapses. 1152 
The data shown are the means ± SEM from 21 (control) and 23 (Lasso-G) individual muscle fibers 1153 
from 5 WT preparations and 36 and 26 muscle fibers from 6 KO preparations. Right, positive 1154 
control: 1 nM LTXN4C increases the frequency of MEPPs in WT, but not in LPHN1 KO 1155 
neuromuscular junctions. The data are the means ± SEM from 21 and 32 individual muscle fibers 1156 
from 6 WT preparations and 36 and 12 muscle fibers from 6 KO preparations. Mann-Whitney test 1157 
with Bonferroni correction for multiple comparisons: *, p < 0.05; **, p < 0.01; ***, p < 0.001; NS, 1158 
non-significant.  1159 
Figure 7²figure supplement 1 1160 
Design of the experiments testing Lasso induced Ca2+ signaling in LPHN1-expressing cells 1161 
and its presynaptic action at mouse neuromuscular junctions. A. Experimental paradigm for 1162 
testing the effect of Lasso-D on LPHN1-dependent Ca2+ signaling. After 5 min recording of 1163 
baseline fluorescence of neuroblastoma cells expressing LPHN1, the cells were treated with 1164 
control buffer (gray arrowhead), 1 nM LTXN4C (black arrowhead) or 360 nM Lasso-D (maroon 1165 
arrowhead). 20 min later 2 mM Ca2+ was added (gray arrowhead) to synchronize the intracellular 1166 
Ca2+ signaling, followed by 1 nM wild-W\SHĮ-latrotoxin (open arrowhead) to induce maximal Ca2+ 1167 
influx through the LTX pore. B. Experimental paradigm for testing the effect of Lasso-D on the 1168 
time-course of LTXN4C-induced LPHN1-dependent Ca2+ signaling. Cells expressing LPHN1 were 1169 
loaded with Fluo-4 and stimulated first with control buffer (black arrowhead) or 1.5 nM Lasso-D 1170 
55 
(maroon arrowhead), and then with 2 nM LTXN4C (blue arrowhead). 1 nM wild-type LTX was added 1171 
at the end (open arrowhead). C. Analysis of the amplitudes of MEPPs recorded at neuromuscular 1172 
junctions from WT and KO mice, indicating a lack of postsynaptic effects of Lasso-G or LTXN4C. 1173 
Left, the mean amplitudes of MEPPs in the absence or presence of Lasso-G. The data are the 1174 
means ± SEM from 21 (control) and 23 (Lasso-G) individual muscle fibers from 5 WT preparations 1175 
and 36 and 26 muscle fibers from 6 KO preparations. Right, the mean amplitudes of MEPPs in 1176 
the absence or presence of 1 nM LTXN4C. The data are the means ± SEM from 21 and 32 1177 
individual muscle fibers from 6 WT preparations and 36 and 12 muscle fibers from 6 KO 1178 
preparations. Mann-Whitney test with Bonferroni correction for multiple comparisons: NS, non-1179 
significant.  1180 
 1181 
Figure 8 1182 
A proposed scheme of the mechanism of axonal attraction by released Lasso ECD. When 1183 
Lasso binds the NTF of LPHN1, it causes its re-DVVRFLDWLRQZLWKWKH&7)7KLVDFWLYDWHV*Įq/11 1184 
and triggers the PLC signaling cascade. Downstream of this cascade, the local IP3-induced 1185 
calcium release (IICR) from intracellular stores stimulates exocytosis and may also stimulate 1186 
reorganization of actin through Ca2+/calmodulin-dependent protein kinase II (CaMKII), thus 1187 
mediating axonal attraction. The dashed line represents LPHN1-mediated activation of neuronal 1188 
adhesion molecules via an unknown mechanism that may lead to axonal fasciculation observed 1189 
in the presence of soluble Lasso (Figure 5C, F).  1190 
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